Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niclosamide as adjuvant to etanercept in rheumatoid arthritis
NCT03160001Phase 2Completed
- Start
- Aug 2017
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Placebo and etanercept with Niclosamide and etanercept (2 arms). Primary endpoint: Change in disease activity scale at Day 1. Started Aug 2017; status: completed.
02
Drugs
niclosamide
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03160001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03160001.